Fig. 11.
Consequence of mdr1 mutation for drug exposure in the central nervous system. (A) functional MDR1 receptor actively lowers concentration of APIs within the central nervous system, while (B) mdr1 mutation nt230 (del4), leading to a non-functional, truncated MDR1 channel, results in accumulation of APIs within brain cells, thus increasing susceptibility to neurotoxic side effects.